Monk BJ

No ORCID on file · 5 papers in corpus · active 2013-2026

Study types

  • erratum 1
  • review 1

Condition tags

  • endometriosis 2
erratum 2026
Corrigendum to 'Endometriosis and ovarian cancer risk' [Gynecologic Oncology 209C (2026) 88-98]
Gynecologic oncology ·doi:10.1016/j.ygyno.2026.05.029
review 2026
Endometriosis and ovarian cancer risk
Gynecologic oncology ·doi:10.1016/j.ygyno.2026.05.004

OBJECTIVE: To critically evaluate the evidence linking endometriosis to ovarian cancer, with particular focus on endometrioid and clear cell histologic subtypes, and to inform risk stratification and patient counseling. METHODS: A systemat…

2023
Identification of Endometrial Cancer-Specific microRNA Biomarkers in Endometrial Fluid.
International journal of molecular sciences ·doi:10.3390/ijms24108683

Abnormal uterine bleeding is a common benign gynecological complaint and is also the most common symptom of endometrial cancer (EC). Although many microRNAs have been reported in endometrial carcinoma, most of them were identified from tumo…

2018
A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254).
Gynecologic Oncology ·doi:10.1016/j.ygyno.2018.05.029

ObjectivesTo determine the efficacy and tolerability of sunitinib in recurrent or persistent clear cell ovarian cancer patients.MethodsAll patients had one or two prior regimens with measurable disease. Tumors were at least 50% clear cell h…

2013
Latest research and treatment of advanced-stage epithelial ovarian cancer.
Nature reviews. Clinical oncology ·doi:10.1038/nrclinonc.2013.5

The natural history of ovarian cancer continues to be characterized by late-stage presentation, metastatic bulky disease burden and stagnant mortality statistics, despite prolific drug development. Robust clinical investigation, particularl…